Patent ID: 9186374
Filing Date: 2015-11-17
Classification: A61K,A61M,A61P

Abstract:
1. A kit comprising: A) a composition for nasal administration of a cobalamin compound, the composition comprising an aqueous solution containing about 0.02% w/w to about 1% w/w of a cobalamin compound and a pharmaceutically acceptable buffer, wherein the composition is sterile, wherein the composition is free of preservatives, wherein the composition has a pH of about 4 to about 6.5, and wherein the cobalamin compound is cyanocobalamin or hydroxocobalamin; and B) a container equipped with a pump adapted to deliver the composition into a patient's nostril, wherein the container is configured such that the dose of the cobalamin compound delivered with each administration is from about 5 μg to about 45 μg.